Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2006 1
2018 1
2019 15
2020 5138
2021 6574
2022 4255
2023 2897
2024 1371

Text availability

Article attribute

Article type

Publication date

Search Results

16,144 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics of SARS-CoV-2 and COVID-19.
Hu B, Guo H, Zhou P, Shi ZL. Hu B, et al. Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6. Nat Rev Microbiol. 2021. PMID: 33024307 Free PMC article. Review.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, named 'coro …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly tran …
COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.
Ochani R, Asad A, Yasmin F, Shaikh S, Khalid H, Batra S, Sohail MR, Mahmood SF, Ochani R, Hussham Arshad M, Kumar A, Surani S. Ochani R, et al. Infez Med. 2021 Mar 1;29(1):20-36. Infez Med. 2021. PMID: 33664170 Free article. Review.
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, first emerged in Wuhan, China, in December 2019 and by March 2020, it was declared a pandemic …
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative p …
Virology, Epidemiology, Pathogenesis, and Control of COVID-19.
Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Jin Y, et al. Viruses. 2020 Mar 27;12(4):372. doi: 10.3390/v12040372. Viruses. 2020. PMID: 32230900 Free PMC article. Review.
The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organiza …
The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV- …
BNT162b2 mRNA COVID-19 Vaccine: First Approval.
Lamb YN. Lamb YN. Drugs. 2021 Mar;81(4):495-501. doi: 10.1007/s40265-021-01480-7. Drugs. 2021. PMID: 33683637 Free PMC article. Review.
BNT162b2 (Comirnaty(); BioNTech and Pfizer) is a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine for the prevention of the novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome cor …
BNT162b2 (Comirnaty(); BioNTech and Pfizer) is a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine for the prevention of the n …
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies.
Salian VS, Wright JA, Vedell PT, Nair S, Li C, Kandimalla M, Tang X, Carmona Porquera EM, Kalari KR, Kandimalla KK. Salian VS, et al. Mol Pharm. 2021 Mar 1;18(3):754-771. doi: 10.1021/acs.molpharmaceut.0c00608. Epub 2021 Jan 19. Mol Pharm. 2021. PMID: 33464914 Review.
Even at the molecular level, many parallels have been identified between SARS and COVID-19 so much so that the COVID-19 virus has been named SARS-CoV-2. ...Moreover, we discussed the molecular mechanisms that enable SARS- …
Even at the molecular level, many parallels have been identified between SARS and COVID-19 so much so that the COVID- …
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, Sundar R, Soon YY. Lee ARYB, et al. BMJ. 2022 Mar 2;376:e068632. doi: 10.1136/bmj-2021-068632. BMJ. 2022. PMID: 35236664 Free PMC article.
OBJECTIVE: To compare the efficacy of covid-19 vaccines between immunocompromised and immunocompetent people. ...DATA SOURCES: PubMed, Embase, Central Register of Controlled Trials, COVID-19 Open Research Dataset Challenge (CORD-19), and WHO …
OBJECTIVE: To compare the efficacy of covid-19 vaccines between immunocompromised and immunocompetent people. ...DATA S …
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2.
Firouzabadi N, Ghasemiyeh P, Moradishooli F, Mohammadi-Samani S. Firouzabadi N, et al. Int Immunopharmacol. 2023 Apr;117:109968. doi: 10.1016/j.intimp.2023.109968. Epub 2023 Mar 2. Int Immunopharmacol. 2023. PMID: 37012880 Free PMC article. Review.
The current review mainly focuses on the effectiveness and safety of COVID-19 vaccines against SARS-CoV-2 variants. Along with discussing the available and approved vaccines, characteristics of different variants of COVID-19 …
The current review mainly focuses on the effectiveness and safety of COVID-19 vaccines against SARS-CoV- …
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review.
Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Ye Z, et al. Eur Radiol. 2020 Aug;30(8):4381-4389. doi: 10.1007/s00330-020-06801-0. Epub 2020 Mar 19. Eur Radiol. 2020. PMID: 32193638 Free PMC article. Review.
Coronavirus disease 2019 (COVID-19) outbreak, first reported in Wuhan, China, has rapidly swept around the world just within a month, causing global public health emergency. ...Emerging atypical CT manifestations, including airway changes, pleural changes, fi …
Coronavirus disease 2019 (COVID-19) outbreak, first reported in Wuhan, China, has rapidly swept around the world just w …
Long COVID syndrome-associated brain fog.
Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, Barzegar Z, Kabiri M, Zeraatpisheh Z, Farjoud-Kouhanjani M, Jafari A, Sasannia S, Ashrafi S, Nazeri M, Nasiri S, Shahisavandi M. Asadi-Pooya AA, et al. J Med Virol. 2022 Mar;94(3):979-984. doi: 10.1002/jmv.27404. Epub 2021 Oct 24. J Med Virol. 2022. PMID: 34672377 Free PMC article.
We investigated the frequency of brain fog in a large cohort of patients with documented coronavirus disease-2019 (COVID-19) who have survived the illness. We also scrutinized the potential risk factors associated with the development of brain fog. Adult pati …
We investigated the frequency of brain fog in a large cohort of patients with documented coronavirus disease-2019 (COVID-19 …
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
Hall V, Foulkes S, Insalata F, Kirwan P, Saei A, Atti A, Wellington E, Khawam J, Munro K, Cole M, Tranquillini C, Taylor-Kerr A, Hettiarachchi N, Calbraith D, Sajedi N, Milligan I, Themistocleous Y, Corrigan D, Cromey L, Price L, Stewart S, de Lacy E, Norman C, Linley E, Otter AD, Semper A, Hewson J, D'Arcangelo S, Chand M, Brown CS, Brooks T, Islam J, Charlett A, Hopkins S; SIREN Study Group. Hall V, et al. N Engl J Med. 2022 Mar 31;386(13):1207-1220. doi: 10.1056/NEJMoa2118691. Epub 2022 Feb 16. N Engl J Med. 2022. PMID: 35172051 Free PMC article.
BACKGROUND: The duration and effectiveness of immunity from infection with and vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relevant to pandemic policy interventions, including …
BACKGROUND: The duration and effectiveness of immunity from infection with and vaccination against severe acute respiratory …
16,144 results
You have reached the last available page of results. Please see the User Guide for more information.